An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations

Frances O Flanagan1, Alexander M Holtz2, Sara O Vargas3

  • 1Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, and Harvard Medical School, Boston, MA, USA.

NPJ Genomic Medicine
|March 6, 2023
PubMed

Insights

A TBX4 gene variant caused respiratory failure and pulmonary hypertension in an infant, demonstrating variable disease presentation and the importance of genetic testing for families. This highlights TBX4 mutations in cardiopulmonary phenotypes.

Area of Science:

  • Genetics
  • Pediatrics
  • Pulmonology

Background:

  • Neonatal respiratory failure and pulmonary hypertension can present with complex etiologies.
  • TBX4 gene mutations are associated with skeletal abnormalities and can impact cardiopulmonary development.
  • Understanding genotype-phenotype correlations is crucial for diagnosing rare genetic disorders.

Purpose of the Study:

  • To investigate the genetic basis of a biphasic cardiopulmonary presentation in an infant.
  • To characterize the functional impact of a novel intronic TBX4 gene variant.
  • To illustrate the spectrum of TBX4-associated phenotypes within a family.

Main Methods:

  • Clinical case presentation of an infant with respiratory distress and pulmonary hypertension.
  • Identification of a TBX4 gene variant using genetic sequencing.
  • Analysis of TBX4 gene expression in patient-derived cells.

Main Results:

  • An intronic TBX4 variant (c.401+3A>T) was identified in the infant, father, and deceased sister.
  • The variant led to reduced TBX4 expression in patient cells.
  • Variable expressivity was observed, ranging from acinar dysplasia and neonatal death to skeletal phenotypes and pulmonary hypertension.

Conclusions:

  • This intronic TBX4 variant contributes to a spectrum of cardiopulmonary and skeletal phenotypes.
  • The study highlights the variable expressivity of TBX4 mutations.
  • Genetic diagnostics are essential for identifying and classifying affected individuals in families with TBX4-related disorders.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
223
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
296
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
291
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
399
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
320